img

Valdecoxib

Valdecoxib is a non-steroidal anti-inflammatory drug used in the treatment of osteoarthritis, rheumatoid arthritis, and painful menstruation and menstrual symptoms. It is a selective cyclooxygenase-2 inhibitor. More

Sharing is caring, show love and share the thread with your friends.

Description

Valdecoxib is a non-steroidal anti-inflammatory drug used in the treatment of osteoarthritis, rheumatoid arthritis, and painful menstruation and menstrual symptoms. It is a selective cyclooxygenase-2 inhibitor.

Generic Name

Valdecoxib

Chemical names

Valdecoxib; Bextra; 4-(5-methyl-3-phenylisoxazol-4-yl) benzenesulfonamide; 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide

Brand names

Artival, Bioval, Creval, Leap, Mobyle-V-20, Nizox, Osra, Oval-20, Parovi, Powercoxib, Revaldo, Revaldo Gel, Revaldo QR, Ronaldo, Tpveld, Vabra, Vabra-P, Vabra-SPD, Vabra-TZ, Vacox, VAH, Vah Gel, Vahflam, VAL-BCD, Valac, Valcib, Valcox Plus, Valdegesic, Valdegesic-P, Valdepain, Valdez, Valdiff, Valdiflam, Valdine, Valdixx MD, Valdone, Valdy, Valdy-MD, Valed, Valeron, Valeron Plus, Valigud, Valiy, Valk, Valk Plus, Valoxib, Valsafe, Valsafe-MR, Valto, Valus.

IUPAC name

4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonamide

Pharmacokinetics

NA

Actions

Valdecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, is classified as a nonsteroidal anti-inflammatory drug (NSAID). Valdecoxib is used for its anti-inflammatory, analgesic, and antipyretic activities in the management of osteoarthritis (OA) and for the treatment of dysmenorrhea or acute pain. 

Dosage/Dosage form

10 mg once daily oral.

Therapeutic uses

For the treatment of osteoarthritis and dysmenorrhoea

Adverse effects/Side effects

Toxic epidermal necrolysis, exfoliative dermatitis. Hypertension, back pain, myalgia, peripheral oedema, influenza-like symptoms, dizziness, headache, abdominal fullness, abdominal pain, diarrhoea, dyspepsia, flatulence, nausea, myalgia, sinusitis.

Interaction

  • Concomitant admin of aspirin may result in an increased risk of GI ulceration and complications.
  • It decreases the antihypertensive effect of antihypertensive e.g. ACE inhibitors.
  •  It increases plasma concentration of dextromethorphan.
  •  It significantly decreases lithium serum clearance and renal clearance.

Contraindications

Hypersensitivity to sulfonamides, NSAIDs and other COX 2 inhibitors; asthma, urticaria; severe hepatic impairment; pregnancy (third trimester); lactation. Active GI bleed or ulceration, severe CHF, inflammatory bowel disease.

Storage

Store below 30°C.

Information

Molecular weight

314.359

Molecular formula

C16H14N2O3S

CAS number

181695-72-7

Precautions

  • Mild to moderate hepatic impairment; history of ulcer disease or GI bleeding; dehydration, hypertension, history of heart failure, left ventricular dysfunction, pre-existing oedema.
  • Monitor Hb or haematocrit values for signs and symptoms of anaemia.